Literature DB >> 28662557

Reducing Off-Label Antipsychotic Use in Older Community-Dwelling Adults With Dementia: A Narrative Review.

Kevin T Bain, Emily J Schwartz, Rengena Chan-Ting.   

Abstract

The off-label use of antipsychotics for the management of behavioral and psychologic symptoms of dementia (BPSD) in older adults (age ≥65 years) is common, despite evidence of modest benefits and serious risks. Although national initiatives aimed at reducing antipsychotic use among older adults with BPSD in nursing homes have been successful, similar initiatives are lacking for community-dwelling adults with dementia. As a result, older adults with BPSD residing in the community may be at an even greater risk of being negatively affected by antipsychotic use. Physicians should be knowledgeable of this issue and understand the alternatives to antipsychotics, as well as how to reduce antipsychotic use in patients with dementia who are already taking antipsychotics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28662557     DOI: 10.7556/jaoa.2017.090

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  3 in total

1.  Trajectories of physical frailty and cognitive impairment in older adults in United States nursing homes.

Authors:  Yiyang Yuan; Kate L Lapane; Jennifer Tjia; Jonggyu Baek; Shao-Hsien Liu; Christine M Ulbricht
Journal:  BMC Geriatr       Date:  2022-04-19       Impact factor: 4.070

Review 2.  Polypharmacy among COVID-19 patients: A systematic review.

Authors:  Sorochi Iloanusi; Osaro Mgbere; Ekere J Essien
Journal:  J Am Pharm Assoc (2003)       Date:  2021-05-26

3.  Increased All-Cause Mortality by Antipsychotic Drugs: Updated Review and Meta-Analysis in Dementia and General Mental Health Care.

Authors:  Stephen J Ralph; Anthony J Espinet
Journal:  J Alzheimers Dis Rep       Date:  2018-02-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.